Khan A M, Shabarek F M, Zwischenberger J B, Warner B W, Cheu H W, Jaksic T, Goretsky M J, Meyer T A, Doski J, Lally K P
Department of Pediatrics, University of Texas Medical School and Hermann Children's Hospital, Houston, USA.
J Pediatr Surg. 1998 Aug;33(8):1229-32. doi: 10.1016/s0022-3468(98)90156-7.
BACKGROUND/PURPOSE: Intracranial hemorrhage (ICH) is a major concern during extracorporeal membrane oxygenation (ECMO). Daily cranial ultrasonography has been used by many ECMO centers as a diagnostic tool for both detecting and following ICH while infants are on bypass. The purpose of this patient review was to look at the usefulness of performing daily cranial ultrasonography (HUS) in infants on ECMO in detecting intraventricular hemorrhage of a magnitude sufficient to alter patient treatment.
The authors reviewed retrospectively all of the records of all neonates treated with ECMO at the Hermann Children's Hospital, Wilford Hall USAF Medical Center, Cincinnati Children's Hospital, The University of Texas Medical Branch at Galveston, and Texas Children's Hospital between February 1986 to March 1995. Two hundred ninety-eight patients were placed on ECMO during this period. All patients had HUS before, and daily while on ECMO, and all were reviewed by the staff radiologists. A total of 2,518 HUS examinations were performed.
Fifty-two of 298 patients (17.5%) had an intraventricular hemorrhage seen on ultrasound scan. Nine of 52 patients (17.3%) had an ICH seen on the initial HUS examination before ECMO, all of which were grade I, and 43 of 52 patients (82.7%) had ICH while on ECMO. Of these ICH, 15 were grade I, 10 were grade II, 10 were grade III, and eight were grade IV. Forty of these ICH (93%) were diagnosed by HUS during the first 5 days of the ECMO course. Seven hundred eighty-six HUS were performed after day 5, at an estimated cost of $300,000 to $450,000 (charges), demonstrating three new intraventricular hemorrhages, one grade I, and one grade IV on day 7 and one grade I on day 8. Eight patients were taken off ECMO because of ICH diagnosed within the first 5 days. One patient was taken off ECMO because of ICH diagnosed after 5 days. This patient had clinical symptoms suggestive of ICH.
Almost all ICH occur during the first 5 days of an ECMO course. Unless there is a clinical suspicion, it is not cost effective to perform HUS after the fifth day on ECMO, because subsequent HUS examinations are unlikely to yield information significant enough to alter management.
背景/目的:颅内出血(ICH)是体外膜肺氧合(ECMO)期间的一个主要问题。许多ECMO中心将每日头颅超声检查用作一种诊断工具,用于在婴儿接受体外循环时检测和监测ICH。本患者回顾的目的是研究对接受ECMO治疗的婴儿进行每日头颅超声检查(HUS)在检测足以改变患者治疗的脑室内出血方面的实用性。
作者回顾性分析了1986年2月至1995年3月期间在赫尔曼儿童医院、美国空军威尔福德·霍尔医疗中心、辛辛那提儿童医院、加尔维斯顿德克萨斯大学医学分校和德克萨斯儿童医院接受ECMO治疗的所有新生儿的记录。在此期间,298例患者接受了ECMO治疗。所有患者在接受ECMO治疗前及治疗期间每天都进行了HUS检查,所有检查均由放射科工作人员进行。共进行了2518次HUS检查。
298例患者中有52例(17.5%)在超声扫描中发现脑室内出血。52例患者中有9例(17.3%)在接受ECMO治疗前的首次HUS检查中发现ICH,均为I级,52例患者中有43例(82.7%)在接受ECMO治疗期间出现ICH。在这些ICH中,15例为I级;10例为II级;10例为III级;八例为IV级。这些ICH中有40例(93%)在ECMO治疗过程的前5天通过HUS诊断出来。在第5天后进行了786次HUS检查,估计费用为30万至45万美元(收费),结果显示在第第7天发现了3例新的脑室内出血,1例I级和1例IV级,在第8天发现1例I级。8例患者因在最初5天内诊断出ICH而停止ECMO治疗。1例患者因在5天后诊断出ICH而停止ECMO治疗。该患者有提示ICH的临床症状。
几乎所有ICH都发生在ECMO治疗过程的前5天。除非有临床怀疑,否则在ECMO治疗第5天后进行HUS检查不具有成本效益,因为后续的HUS检查不太可能产生足以改变治疗管理的重要信息。